FDA Inspection 856475 — Cooper Health System IRB
The FDA completed an inspection of Cooper Health System IRB on December 3, 2013 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 3, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Camden, NJ (United States)
Additional Details
IRB